PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced a partnership with Salem State University to offer a Post Graduate Certificate Program in Clinical Trial Management. This collaboration will provide candidates with the education needed to succeed in the growing clinical research management industry.
PAREXEL is committed to developing the future biopharmaceutical workforce with courses specifically tailored to meet the growing talent needs of the clinical development job market. Salem State University is an ideal partner to help further this effort due to its experience in developing academic programs relevant to workforce needs in the healthcare and life science fields.
“Salem State has a progressive outlook in partnering with industries and an impressive track record in building career interest in science disciplines,” said Josef von Rickenbach, Chairman and Chief Executive Officer, PAREXEL International. “PAREXEL has experienced rapid growth in the United States and we are excited to have a major university partner in the Northeast to further develop the much-needed talent pool of candidates in the field.”
“Our partnership with PAREXEL International is a strong example of Salem State’s commitment to working with industry to create workforce aligned programs,” said Patricia Maguire Meservey, president of Salem State University. “There is a clear need here for people with a healthcare or life sciences background who, with the right training, can tap into a specialized area where there is great demand.”
PAREXEL has a well-established history of developing close partnerships with regional universities through its PAREXEL Academy. The company established the first academy of its kind in Berlin, Germany in 2001, where candidates can earn a Bachelor of Science (BSc) in Clinical Research degree validated and awarded by the University of Wales. More recently, PAREXEL entered into an agreement with the National University of Singapore (NUS), through its National University of Singapore Academy of GxP Excellence (NUSAGE), to offer an academic program to help meet the increasing demand for talent in the field of clinical research in the Asia region. Since its inception, PAREXEL International has helped train more than one thousand professionals and has successfully placed many of its graduates into the life sciences industry segment.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.